Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (iv) All inpatient clients, ratio of males to females by country and primary drug

Country		Opioids	Cocaine	Stimulants	Hypnotics and sedatives	Hallucinogens	Volatile substances	Cannabis	Other drugs	Gender and drug known
Belgium	(1)	4.4	4.7	3.0	7.3			10.1		1291
Bulgaria		6.0		4.0	5.0					538
Czech Republic		2.3	1.8	1.6	1.0		3.3	3.5	6.0	1975
Denmark		4.2	4.5	1.6	0.7			4.2	5.3	292
Germany		4.8	9.7	4.9	0.6	10.0	4.0	8.3	3.8	6854
Estonia		:	:	:	:	:	:	:	:	:
Ireland		2.7	8.4	1.8	3.1		1.0	14.2		1021
Greece		6.2	4.0		3.0	1.0		6.4	0.0	2145
Spain		:	:	:	:	:	:	:	:	:
France		3.8	17.0		4.8			2.2		222
Italy		:	:	:	:	:	:	:	:	:
Cyprus		8.7	16.0					3.7		99
Latvia		3.2	3.0	2.9	1.1		10.3	3.8		761
Lithuania
Luxembourg		3.1	1.1	0.5	1.0			2.7		98
Hungary		:	:	:	:	:	:	:	:	:
Malta		:	:	:	:	:	:	:	:	:
Netherlands		:	:	:	:	:	:	:	:	:
Austria		2.6	6.1	4.6	2.0			5.4		1277
Poland		:	:	:	:	:	:	:	:	:
Portugal		:	:	:	:	:	:	:	:	:
Romania		6.3		8.5	0.8		18.0	9.7	1.4	1393
Slovenia		:	:	:	:	:	:	:	:	:
Slovakia		2.4		5.0	1.0		18.3	5.6		522
Finland		2.3		1.8	1.9			3.3	1.3	1002
Sweden		2.3	12.5	1.8	1.8			5.4	4.7	3047
Uk		2.5	2.6	1.9	2.4	2.0	0.8	2.2	1.7	3652
Croatia		3.2	6.7	10.0	1.0		8.0	8.4	3.8	949
Turkey		13.3	11.3	10.6	6.4		112.5	40.2	12.5	2492
Norway		:	:	:	:	:	:	:	:	:
Total		3.7	5.1	2.2	1.4	12.7	18.0	8.0	3.2	3.6
Total base		16648	2101	3997	1418	41	380	4016	1029	29630

Notes:

 : indicates data not available 

 Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented. 

 (1) Last available data refer to 2005 and to outpatient centres and low-threshold agencies (aggregated data). Brussels Capital Region is not covered. For Hallucinogens 6 male cases have been reported 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2008 — TDI — inpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)